Publications 2019 - Equipe 2

  • Magnen M, Gueugnon F, Petit-Courty A, Baranek T, Sizaret D, Brewah YA, Humbles AA, Si-Tahar M, Courty Y. Tissue kallikrein regulates alveolar macrophage apoptosis early in influenza virus infection. Am J Physiol Lung Cell Mol Physiol. 2019 Jun 1;316(6):L1127-L1140. doi: 10.1152/ajplung.00379.2018. Epub 2019 Mar 25. PMID: 30908937.
  • Lalmanach G. What's up in the proteolysis landscape? A lively blend of classical concepts and pioneering innovations. Biochimie. 2019 Nov;166:1-3. doi: 10.1016/j.biochi.2019.10.001. Epub 2019 Oct 2. PMID: 31586457.
  • Lamort AS, Hamon Y, Czaplewski C, Gieldon A, Seren S, Coquet L, Lecaille F, Lesner A, Lalmanach G, Gauthier F, Jenne D, Korkmaz B. Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis. Int J Mol Sci. 2019 Sep 25;20(19):4747. doi: 10.3390/ijms20194747. PMID: 31557781; PMCID: PMC6801622.
  • Andrault PM, Schamberger AC, Chazeirat T, Sizaret D, Renault J, Staab- Weijnitz CA, Hennen E, Petit-Courty A, Wartenberg M, Saidi A, Baranek T, Guyetant S, Courty Y, Eickelberg O, Lalmanach G, Lecaille F. Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD. Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L625-L638. doi: 10.1152/ajplung.00061.2019. Epub 2019 Sep 25. PMID: 31553637.
  • Wartenberg M, Saidi A, Galibert M, Joulin-Giet A, Burlaud-Gaillard J, Lecaille F, Scott CJ, Aucagne V, Delmas AF, Lalmanach G. Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe. Biochimie. 2019 Nov;166:84-93. doi: 10.1016/j.biochi.2019.03.013. Epub 2019 Mar 23. PMID: 30914255.
  • Saidi A, Kasabova M, Vanderlynden L, Wartenberg M, Kara-Ali GH, Marc D, Lecaille F, Lalmanach G. Curcumin inhibits the TGF-β1-dependent differentiation of lung fibroblasts via PPARγ-driven upregulation of cathepsins B and L. Sci Rep. 2019 Jan 24;9(1):491. doi: 10.1038/s41598-018-36858-3. PMID: 30679571; PMCID: PMC6345753.
  • Rehm SRT, Smirnova NF, Morrone C, Götzfried J, Feuchtinger A, Pedersen J, Korkmaz B, Yildirim AÖ, Jenne DE. Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation. Sci Rep. 2019 Jul 9;9(1):9925. doi: 10.1038/s41598-019-46206-8. PMID: 31289357; PMCID: PMC6616352.
  • Korkmaz B, Lesner A, Wysocka M, Gieldon A, Håkansson M, Gauthier F, Logan DT, Jenne DE, Lauritzen C, Pedersen J. Structure-based design and in vivo anti- arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C. Biochem Pharmacol. 2019 Jun;164:349-367. doi: 10.1016/j.bcp.2019.04.006. Epub 2019 Apr 9. PMID: 30978322.
  • Grzywa R, Lesner A, Korkmaz B, Sieńczyk M. Proteinase 3 phosphonic inhibitors. Biochimie. 2019 Nov;166:142-149. doi: 10.1016/j.biochi.2019.03.005. Epub 2019 Mar 13. PMID: 30876969.
  • Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. PMID: 31566307
  • Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, Selman M, Rohr KB, Michael A, Ittrich C, Diefenbach C, Jenkins RG; INMARK trial investigators. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. Lancet Respir Med. 2019 Sep;7(9):771-779. doi: 10.1016/S2213-2600(19)30255-3. Epub 2019 Jul 17. PMID: 31326319.
  • Tabèze L, Marchand-Adam S, Borie R, Justet A, Dupin C, Dombret MC, Crestani B, Taillé C. Severe asthma with blood hypereosinophilia associated with JAK2</V617F mutation: a case series. Eur Respir J. 2019 Jun 13;53(6):1802248. doi: 10.1183/13993003.02248-2018. PMID: 31000675.
  • Jouneau S, Gamez AS, Traclet J, Nunes H, Marchand-Adam S, Kessler R, Israël- Biet D, Borie R, Strombom I, Scalori A, Crestani B, Valeyre D, Cottin V. A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT. Respiration. 2019;98(1):19-28. doi: 10.1159/000496735. Epub 2019 Apr 9. PMID: 30965332.
  • Gut-Gobert C, Cavaillès A, Dixmier A, Guillot S, Jouneau S, Leroyer C, Marchand-Adam S, Marquette D, Meurice JC, Desvigne N, Morel H, Person-Tacnet C, Raherison C. Women and COPD: do we need more evidence? Eur Respir Rev. 2019 Feb 27;28(151):180055. doi: 10.1183/16000617.0055-2018. PMID: 30814138.
  • Klotz LV, Courty Y, Lindner M, Petit-Courty A, Stowasser A, Koch I, Eichhorn ME, Lilis I, Morresi-Hauf A, Arendt KAM, Pepe M, Giopanou I, Ntaliarda G, Behrend SJ, Oplopoiou M, Gissot V, Guyetant S, Marchand-Adam S, Behr J, Kaiser JC, Hatz RA, Lamort AS, Stathopoulos GT. Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors. Cancer Med. 2019 Apr;8(4):1486-1499. doi: 10.1002/cam4.2031. Epub 2019 Feb 25. PMID: 30806043; PMCID: PMC6488114.